Capsugel Launches Enteric Drug Delivery Technology Platform
Capsugel has announched the global commercial launch of its enTRinsic drug delivery technology platform, which provides enteric protection and targeted release of gastric acid- and heat-sensitive active ingredients to the upper gastrointestinal tract, without the need for functional coatings.
Capsugel's technology enables oral delivery of a variety of compounds, including vaccines, proteins and peptides, using pharmaceutically approved enteric polymers. The technology is globally available for customer projects following the successful completion of an 18-month lead-user customer-collaboration program that included feasibility studies with new and existing pharmaceutical products.
Customers can access the technology platform through a services agreement at Capsugel's locations in PloÃ«rmel, France, and Bend, Oregon.